# Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation

> **NCT02176265** · NA · COMPLETED · sponsor: **Qvanteq AG** · enrollment: 31 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Qvanteq bioactive coronary stent

## Key facts

- **NCT ID:** NCT02176265
- **Lead sponsor:** Qvanteq AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-02
- **Final completion:** 2016-08
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2016-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176265, "Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02176265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*